Table 3.
EORTC C30a results from 33 patients treated with gastroduodenal stents
| Before | After | Difference | P value | |
|---|---|---|---|---|
| Global health functionb | 22.0 (19.3) | 38.4 (26.4) | 16.4 (24.8) | <0.001 |
| Symptom scalesb | ||||
| Pain | 57.6 (28.6) | 39.9 (36.3) | 17.7 (36.3) | 0.014 |
| Nausea/vomiting | 63.1 (31.1) | 30.3 (27.5) | 32.8 (38.7) | <0.001 |
| Single itemsb | ||||
| Appetite lossc | 81.8 (25.1) | 65.7 (37.7) | 16.2 (34.5) | 0.013 |
All values are mean (SD)
aA selection of the EORTC QLQ-C30 most relevant scorings was made; no significant change was found in the excluded scores
bScale from 0 to 100; high scores represent more severe symptoms
cScale from 0 to 100; high scores represent higher level of overall functioning